SOHO UK mirrors traditional SOHO meeting with UK twist
SOHO UK is intended to set a precedent as the start of a continuing platform that will return at regular intervals and provide
SOHO UK
Leukemia
Acute Lymphoblastic Leukemia
News
Society Updates
SOHO UK
Lymphoma
Aggressive B-Cell Lymphomas
T-Cell Lymphoma
Meetings / Conferences
Prof. Cwynarski previews CNS, peripheral T-cell lymphoma sessions ahead of SOHO UK
Prof. Kate Cwynarski, MD, PhD, joined SOHO Insider podcast host Megan Melody, MD, for a discussion previewing lymphoma sessions she will lead at
ASH 2025
Dr. Lane discusses results of triplet combo in BPCDN
Andrew Lane, MD, PhD, of Dana Farber Cancer Institute, reports the results from a phase 2 trial in tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet
Cellular Therapy
Lymphoma
Indolent B-Cell Lymphomas
News
Liso-cel shows good 3-year response, safety results in patients with R/R follicular lymphoma
Patients in the TRANSCEND FL study received liso-cel after lymphodepleting chemotherapy (LDC). Bridging therapy was allowed with reconfirmation of PET-positive disease before LDC.
SOHO UK
Ambassador Program
Prof. Craddock discusses 1st SOHO UK set for 3–4 March 2026 in London
Prof. Charlie Craddock, CBE, discusses what to expect at the first SOHO UK, which will be held 3–4 March 2026 in London at
Community Oncology News
Past Sessions
Trending now
Community Oncology
Cellular Therapy
Video Interviews
Video: Dr. Graff on implementing bispecific antibodies in community practice
Live session held on February 11, 2026, from 2:00–2:30 PM CST with speaker Tara Graff presenting on "Implementing Bispecific Antibodies in Community Practice."
SOHO Asia 2026
Acute Myeloid Leukemia
Video Interviews
John DiPersio, MD, PhD, provides AML highlights from SOHO Asia
In this video from SOHO Asia 2026, Dr. DiPersio discusses highlights from the acute myeloid leukemia session with Drs. Andrew Wei, Naval Daver,
Cellular Therapy
Leukemia
Orca-T immunotherapy improves QOL, resource use over conventional allogeneic HSCT
Orca-T, an investigational allogeneic T-cell immunotherapy, led to better quality-of-life outcomes and lower healthcare resource use than standard treatment with conventional allograft with
SOHO 2026
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
Mantle Cell Lymphoma
T-Cell Lymphoma
News
SOHO 2026 abstract submissions are now open
SOHO invites delegates and attendees to submit an abstract for a poster or oral presentation during the Fourteenth Annual Meeting of the Society